Terms: = Colorectal cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Treatment
24140 results:
1. Advancing mid-rectal cancer surgery: Unveiling the potential of natural orifice specimen extraction surgery in comparison to conventional laparoscopic-assisted resection.
Muhammad S; Jiang Z; Fan T; Tang Q; Hai Y; Ehsan SBE; Bilal M; Zubayraeva AA; Gao Y; He J
Cancer Rep (Hoboken); 2024 May; 7(5):e2003. PubMed ID: 38703000
[TBL] [Abstract] [Full Text] [Related]
2. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.
Pourfaraji SM; Moghadam MN; Moradi AM; Shirmard FO; Mohammadzadeh N; Jafarian A
BMC Surg; 2024 May; 24(1):131. PubMed ID: 38702645
[TBL] [Abstract] [Full Text] [Related]
3. An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal cancer.
Custers PA; Beets GL; Bach SP; Blomqvist LK; Figueiredo N; Gollub MJ; Martling A; Melenhorst J; Ortega CD; Perez RO; Smith JJ; Lambregts DMJ; Beets-Tan RGH; Maas M
Dis Colon Rectum; 2024 Jun; 67(6):782-795. PubMed ID: 38701503
[TBL] [Abstract] [Full Text] [Related]
4. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.
Ding W; Chen L; Xia J; Pei B; Song B; Li X
Medicine (Baltimore); 2024 May; 103(18):e38010. PubMed ID: 38701318
[TBL] [Abstract] [Full Text] [Related]
5. Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab - a non-interventional observational study.
Fínek J; Vočka M; Bauer J; Kubala E; Zycháčková K; Šedivá M; Gharibyar M; Kocáková I; Čmuchařová E; Vaňková M
Klin Onkol; 2024; 38(2):110-117. PubMed ID: 38697819
[TBL] [Abstract] [Full Text] [Related]
6. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.
Wlodarski MW; Vlachos A; Farrar JE; Da Costa LM; Kattamis A; Dianzani I; Belendez C; Unal S; Tamary H; Pasauliene R; Pospisilova D; de la Fuente J; Iskander D; Wolfe L; Liu JM; Shimamura A; Albrecht K; Lausen B; Bechensteen AG; Tedgard U; Puzik A; Quarello P; Ramenghi U; Bartels M; Hengartner H; Farah RA; Al Saleh M; Hamidieh AA; Yang W; Ito E; Kook H; Ovsyannikova G; Kager L; Gleizes PE; Dalle JH; Strahm B; Niemeyer CM; Lipton JM; Leblanc TM;
Lancet Haematol; 2024 May; 11(5):e368-e382. PubMed ID: 38697731
[TBL] [Abstract] [Full Text] [Related]
7. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
[TBL] [Abstract] [Full Text] [Related]
8. The modulation of autophagy and unfolded protein response by ent-kaurenoid derivative CPUK02 in human colorectal cancer cells.
Rezayi S; Siri M; Rahmani-Kukia N; Zamani M; Dastghaib S; Mokarram P
Mol Biol Rep; 2024 Apr; 51(1):599. PubMed ID: 38689181
[TBL] [Abstract] [Full Text] [Related]
9. High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience.
Manfrida S; Fionda B; Mariani S; Luca V; Bertolini R; Barbaro B; Chiloiro G; Frascino V; Tagliaferri L; Gambacorta MA
In Vivo; 2024; 38(3):1306-1315. PubMed ID: 38688632
[TBL] [Abstract] [Full Text] [Related]
10. Impact of Neoadjuvant Radiochemotherapy on Pathological Complete Response for Locally Advanced Rectal cancer: A Mono Institutional Experience.
Lucarelli M; Gentile V; Bonelli R; Pasquale G; Pizzi AD; Nicola MD; Porreca A; Genovesi D
In Vivo; 2024; 38(3):1367-1374. PubMed ID: 38688610
[TBL] [Abstract] [Full Text] [Related]
11. Outcomes of colorectal Endoscopic Submucosal Dissection for Elderly Patients: A Multicenter Study by the Honam Association for the Study of Intestinal Disease (HASID).
Jin BC; Kim DH; Oh HH; Song HY; Kim SJ; Myung DS; Joo YE; Lee J; Kim HS; Seo GS; Kim SW
In Vivo; 2024; 38(3):1405-1411. PubMed ID: 38688593
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
[TBL] [Abstract] [Full Text] [Related]
13. Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids.
Bustamante-Madrid P; Barbáchano A; Albandea-Rodríguez D; Rodríguez-Cobos J; Rodríguez-Salas N; Prieto I; Burgos A; Martínez de Villarreal J; Real FX; González-Sancho JM; Larriba MJ; Lafarga M; Muñoz A; Fernández-Barral A
Cell Death Dis; 2024 Apr; 15(4):301. PubMed ID: 38684650
[TBL] [Abstract] [Full Text] [Related]
14. Synthesis and SAR investigation of biphenylaminoquinoline derivatives with benzyloxy substituents as promising anticancer agents.
Wu YC; Lu MT; Kuo SC; Chu PC; Chang CS
Chem Biol Drug Des; 2024 May; 103(5):e14509. PubMed ID: 38684369
[TBL] [Abstract] [Full Text] [Related]
15. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract] [Full Text] [Related]
16. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in colorectal Carcinoma Cells.
Jacksi M; Schad E; Tantos A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
[TBL] [Abstract] [Full Text] [Related]
17. H
Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
[TBL] [Abstract] [Full Text] [Related]
18. Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment.
Ottaiano A; Santorsola M; Ianniello M; Ceccarelli A; Casillo M; Sabbatino F; Petrillo N; Cascella M; Caraglia F; Picone C; Perri F; Sirica R; Zappavigna S; Nasti G; Savarese G; Caraglia M
J Transl Med; 2024 Apr; 22(1):379. PubMed ID: 38650006
[TBL] [Abstract] [Full Text] [Related]
19. [Relationship Between Tim-3 and Galectin-9 Expression Levels, Clinical Pathological Characteristics, and Prognosis in Patients After Radical Resection of colorectal cancer].
Zhang Y; Deng D; Yin W; Luo J; Liu J; Xie C; Ji X; Ma L; Zhang L; Xia X; Cheng S; Huang A; Yang F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):375-382. PubMed ID: 38645842
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation.
Li F; Liu L; Feng Q; Wang X; Liu F; Yang L; Miao L; Wang W; Ji G; Yu C
World J Surg Oncol; 2024 Apr; 22(1):107. PubMed ID: 38644507
[TBL] [Abstract] [Full Text] [Related]
[Next]
